Genetic alterations in cell-cycle inhibitors p16/MRS1 and p15/MTS2 and growth control in pancreatic tumors.

被引：0
|
作者：
Savitskaia, N [1 ]
Lumma, A [1 ]
Eilert, C [1 ]
Naumann, M [1 ]
Schmiegel, W [1 ]
机构：
[1] RUHR UNIV BOCHUM, KNAPPSCHAFTS KRANKENHAUS, IMBL, MED CLIN, D-44892 BOCHUM, GERMANY
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A428 / A428
页数：1
相关论文
共 50 条
  • [21] Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas
    邵建永
    李宇红
    李晓明
    吴秋良
    侯景辉
    刘宗石
    中华医学杂志(英文版), 2000, (09) : 49 - 54
  • [22] Comparative analysis of Homo sapiens and Mus musculus cyclin-dependent kinase (CDK) inhibitor genes P16 (MTS1) and P15 (MTS2)
    Jiang, P
    Stone, S
    Wagner, R
    Wang, S
    Dayananth, P
    Kozak, CA
    Wold, B
    Kamb, A
    JOURNAL OF MOLECULAR EVOLUTION, 1995, 41 (06) : 795 - 802
  • [23] Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours
    EE Schmidt
    K Ichimura
    KR Messerle
    HM Goike
    VP Collins
    British Journal of Cancer, 1997, 75 : 2 - 8
  • [24] High frequency alterations of the p16 and p15, but not p18, CDK inhibitors in T cell acute lymphoblastic leukemia
    Yu, AL
    Diccianni, MB
    Batova, A
    Vu, T
    Pullen, J
    Amylon, M
    Pollock, B
    Yu, J
    BLOOD, 1995, 86 (10) : 1057 - 1057
  • [25] Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours
    Schmidt, EE
    Ichimura, K
    Messerle, KR
    Goike, HM
    Collins, VP
    BRITISH JOURNAL OF CANCER, 1997, 75 (01) : 2 - 8
  • [26] Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood
    Ohnishi, H
    Hanada, R
    Horibe, K
    Hongo, T
    Kawamura, M
    Naritaka, S
    Bessho, F
    Yanagisawa, M
    Nobori, T
    Yamamori, S
    Hayashi, Y
    LEUKEMIA, 1996, 10 (07) : 1104 - 1110
  • [27] CYCLIN-DEPENDENT KINASE-4 INHIBITORS (P16(INK4A)/MTS1 AND P15(INK4B)/MTS2) GENES STRUCTURE AND EXPRESSION IN HEPATOCELLULAR CARCINOMAS (HCC)
    DELMER, A
    SENAMAUDBEAUFORT, C
    BLANQUET, V
    PATERLINI, P
    BRECHOT, C
    HEPATOLOGY, 1995, 22 (04) : 1205 - 1205
  • [28] MUTATIONS IN THE P16(INK4)/MTS1/CDKN2, P15(INK4B)/MTS2, AND P18 GENES IN PRIMARY AND METASTATIC LUNG-CANCER
    OKAMOTO, A
    HUSSAIN, SP
    HAGIWARA, K
    SPILLARE, EA
    RUSIN, MR
    DEMETRICK, DJ
    SERRANO, M
    HANNON, GJ
    SHISEKI, M
    ZARIWALA, M
    XIONG, Y
    BEACH, DH
    YOKOTA, J
    HARRIS, CC
    CANCER RESEARCH, 1995, 55 (07) : 1448 - 1451
  • [29] Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors:: An analysis of p16/MTS1 tumor suppressor gene inactivation
    Muscarella, P
    Melvin, WS
    Fisher, WE
    Foor, J
    Ellison, EC
    Herman, JG
    Schirmer, WJ
    Hitchcock, CL
    DeYoung, BR
    Weghorst, CM
    CANCER RESEARCH, 1998, 58 (02) : 237 - 240
  • [30] Mutations of CDKN2 (MTS1/p16(INK4A)) and MTS2/p15(INK4B) genes in human stomach, hepatocellular, and cholangio-carcinomas
    Jae-Ryong Kim
    Seong-Yong Kim
    Bong-Hwan Lee
    Sang-Woon Kim
    Hong-Jin Kim
    Jung-Hye Kim
    Experimental & Molecular Medicine, 1997, 29 : 151 - 156
12345